Maze Therapeutics Inc (MAZE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 20,000 | 0 | 0 | 0 | 0 |
| Gross Profit | 20,000 | N/A | N/A | N/A | N/A |
| Operating Expenses | 46,553 | 38,059 | 32,965 | 36,474 | 35,401 |
| Operating Income | -26,553 | -38,059 | -32,965 | -36,474 | -35,401 |
| Interest Expense | 866 | 0 | 0 | 0 | 0 |
| Other Income | 3,211 | 3,491 | 2,878 | 2,795 | 2,615 |
| Pre-tax Income | -24,208 | -34,568 | -30,087 | -33,679 | -32,786 |
| Net Income Continuous | -24,208 | -34,568 | -30,087 | -33,679 | -32,786 |
| Net Income | $-24,208 | $-34,568 | $-30,087 | $-33,679 | $-32,786 |
| EPS Basic Total Ops | -0.45 | -0.47 | -0.66 | -0.77 | -1.15 |
| EPS Basic Continuous Ops | -0.45 | -0.48 | -0.66 | -0.77 | -1.15 |
| EPS Diluted Total Ops | -0.45 | -0.47 | -0.66 | -0.77 | -1.15 |
| EPS Diluted Continuous Ops | -0.45 | -0.48 | -0.66 | -0.77 | -1.15 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.65 | -0.66 | -0.77 | -1.15 |
| EBITDA(a) | $-25,738 | $-37,560 | $-32,394 | $-35,825 | $-34,717 |